Velcade (Bortezomib)

Velcade (bortezomib) is a proteasome inhibitor used primarily for the treatment of certain types of cancer. The main indications for this therapeutic drug include:

Multiple Myeloma (MM): Bortezomib is used both as a monotherapy and in combination with other drugs to treat multiple myeloma (MM), a type of cancer that forms in plasma cells.

Mantle Cell Lymphoma (MCL): Bortezomib is approved for use in patients with mantle cell lymphoma (MCL), a rare and aggressive type of non-Hodgkin lymphoma, particularly for those who have received at least one prior therapy.

Recommended Dosage: The recommended dosage of Bortezomib is 1.3 mg/m², administered either intravenously or subcutaneously. It is typically given twice weekly for two weeks (Days 1, 4, 8, and 11), followed by a 10-day rest period, constituting a 21-day treatment cycle. The specific regimen may vary based on the condition being treated (multiple myeloma or mantle cell lymphoma) and whether it is used in combination with other medications. Always follow the precise dosing and administration guidelines provided by a healthcare professional.

• Treatment with Bortezomib 3.5 mg injection can cause peripheral neuropathy, which may be severe. Patients should be monitored for symptoms such as pain, burning, or tingling in the hands or feet. Dosage adjustments or discontinuation may be necessary if neuropathy occurs.
  
• Patients receiving Bortezomib may experience orthostatic/postural hypotension. Monitoring blood pressure regularly is crucial, especially in patients with a history of fainting, taking antihypertensive medications, or dehydration. Appropriate management includes hydration and dose modifications.
  
• This medicinal product has been associated with heart failure, myocardial ischemia, and other cardiac complications. Patients with existing cardiac conditions should be monitored closely for any signs of cardiac dysfunction, and dosage adjustments should be made as needed.
  
• Acute respiratory distress syndrome (ARDS) and interstitial lung disease (ILD) have been reported with the use of this medicine. Patients should be evaluated for any new or worsening respiratory symptoms, and treatment should be interrupted if severe pulmonary complications arise.
  
• Thrombocytopenia, neutropenia, and anemia are common hematologic toxicities associated with Velcade 3.5 mg injection. Regular monitoring of complete blood counts is necessary, and dose modifications may be required to manage these conditions.
  
• Nausea, diarrhea, constipation, and vomiting are frequent gastrointestinal side effects. Patients should be monitored and provided with supportive care, including antiemetic or antidiarrheal medications as needed.
  
• This therapeutic drug can cause liver enzyme elevations and hepatic failure. Patients with preexisting liver conditions or those experiencing liver enzyme elevations should be monitored closely, and dosage adjustments should be considered to mitigate hepatotoxic effects.

What documents are required to import VELCADE to India?

VELCADE (bortezomib) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable
  

VELCADE (bortezomib injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Velcade in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of VELCADE (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Velcade (bortezomib) price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the VELCADE (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Velcade®?

Bortezomib is a Generic Name for the trade name drug Velcade®.

What is the Manufacturer’s Name of Velcade®?

Velcade® is manufactured by Millennium Pharmaceuticals, Inc.

Is Velcade® approved by the FDA?

Yes, Velcade® is approved by the FDA. Date of first approval: May 13, 2003.

What is the dosage and form of Velcade® supplied?

Velcade® is supplied as an injection: a single-dose vial contains 3.5 mg of bortezomib as a lyophilized powder for reconstitution for subcutaneous or intravenous use. 

What are the most common side effects of Velcade®? 

The most common side effects of Velcade® are nausea, neuralgia, anemia, diarrhea, thrombocytopenia, neutropenia, peripheral neuropathy, fatigue, leukopenia, constipation, vomiting, lymphopenia, pyrexia, rash, and anorexia.

How much does Velcade® cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Velcade 3.5 mg in India, it is recommended to Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Velcade®?

Velcade® (bortezomib) should be stored at a temperature between 25°C (77°F), with excursions permitted to 15-30°C (59-86°F), and kept in its original package to protect from light.

Is it safe to buy Velcade® online in India?

Yes, one can buy Velcade online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Velcade® through legal channels.